🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free)

    CUMBERLAND PHARMACEUTICALS INC

    Acetaminophen Overdose

    phase 3 small molecule terminated

    1 trial

  2. Acetaminophen

    S.L

    Patency of the Ductus Arteriosus

    phase 3 small molecule completed

    1 trial

  3. Acetazolamide Levamisole

    The First People's Hospital of Lianyungang

    HCC

    phase 3 small molecule active

    1 trial

  4. Acoramidis

    BridgeBio Oncology Therapeutics

    Amyloidosis

    phase 3 small molecule active

    3 trials

  5. Acoramidis

    BridgeBio Oncology Therapeutics

    Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

    phase 3 small molecule terminated

    1 trial

  6. Acoramidis (AG10)

    BridgeBio Oncology Therapeutics

    Amyloid Cardiomyopathy, Transthyretin-Related

    phase 3 small molecule active

    1 trial

  7. Acoramidis (AG10)

    BridgeBio Oncology Therapeutics

    Amyloidosis in Transthyretin (TTR)

    phase 3 small molecule active

    1 trial

  8. Actilyse, polvo y disolvente para solución inyectable y para perfusión, Actilyse, polvo y disolvente para solución inyectable y para perfusión

    The George Institute

    People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.

    phase 3 small molecule active

    1 trial

  9. Active

    Aclaris Therapeutics

    Common Wart

    phase 3 small molecule completed

    1 trial

  10. Active CTC Assessment

    United Therapeutics Europe Ltd

    Adenocarcinoma of the Prostate

    phase 3 other terminated

    1 trial

  11. Actovegin

    Takeda

    Peripheral Arterial Diseases

    phase 3 small molecule completed

    1 trial

  12. Acupuncture

    Summit Therapeutics

    Fatigue

    phase 3 other active

    1 trial

  13. Acupuncture (Procedure)

    The University of Hong Kong

    Autistic Disorder

    phase 3 other completed

    1 trial

  14. Adjuvant Immunomodulatory (IM) Therapy

    Ultragenyx UK Limited

    Mucopolysaccharidosis IIIA

    phase 3 small molecule active

    1 trial

  15. Adjuvant chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Total Neoadjuvant Treatment

    phase 3 small molecule active

    1 trial

  16. Adjuvant immunotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  17. Adtralza 150 mg solution for injection in pre-filled syringe, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.

    LEO Pharma A/S

    Treatment of moderate-to-severe Atopic dermatitis

    phase 3 small molecule active

    1 trial

  18. Adynovate

    Takeda

    Hemophilia A

    phase 3 mab completed

    1 trial

  19. Aerobic Exercise

    The First People's Hospital of Lianyungang

    Primary Hypertension

    phase 3 other active

    1 trial

  20. Afatinib

    Boehringer Ingelheim

    Head and Neck Neoplasms

    phase 3 small molecule completed

    1 trial

  21. Afimkibart

    Hoffmann-La Roche

    Moderately to Severely Active Crohns Disease

    phase 3 small molecule active

    1 trial

  22. Afinitor 10 mg tablets, Aromasin 25 mg coated tablets, Faslodex 250 mg solution for injection., Afinitor 5 mg tablets

    Pfizer Australia Pty Ltd

    Hormone receptor-positive, her2-negative advanced/metastatic breast cancer

    phase 3 small molecule active

    1 trial

  23. Afinitor 2.5 mg tablets, Afinitor 10 mg tablets

    The George Institute

    Children, adolescents and adults with newly diagnosed diffuse intrinsic pontine glioma and other diffuse midline gliomas H3K28M mutant or EZHIP positive

    phase 3 small molecule active

    1 trial

  24. Afinitor 5 mg tablets, PLACEBO

    Ningbo Cancer Hospital

    Patients with high risk of relapse, ER+ and HER2- primary non-metastatic breast cancer who remain disease-free

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources